“Pipeline”

39 result(s)
Health Equity
Marketplace Trends Shape Specialty Landscape
... More
Briefing
Specialty
Three Major Challenges Facing Gene Therapy
The Top Challenges Facing Gene Therapy Today More
Briefing
Drug Pipeline
A Q2 2022 Look at Projected Gene Therapies and Approval Timelines
A Q2 2022 Look at Projected Gene Therapies and FDA Approval Timelines More
Briefing
Cost Management
Strategy and Balance: Managing Costs for Pulmonary Arterial Hypertension
Managing Treatment Costs for Pulmonary Arterial Hypertension More
Briefing
Cost Management
A Breath of Fresh Air for Patients with Pulmonary Arterial Hypertension
New Dry Powder Inhalation Therapies for PAH in Pipeline More
Briefing
Specialty
The Role of Biosimilars in Lowering Specialty Costs
Biosimilars Can Be Part of a Strategy to Lower Specialty Drug Costs More
Briefing
Drug Pipeline
Treatment Options Expand in Robust Gene Therapy Pipeline
New Gene Therapies for Sickle Cell Disease, Hemophilia on the Horizon More
Briefing
Drug Pipeline
More Treatments, Costs for Patients with Inflammatory Bowel Disease
As more treatments for inflammatory bowel disease are approved, payors can counter cost increases with comprehensive utilization management. More
Briefing
Drug Pipeline
New Migraine Drugs Near Approval
... More
Briefing
Drug Pipeline
Gene Therapies in the Pipeline Highlight a Variety of Conditions and Anticipated Treatments
The gene therapy pipeline report highlights what payors can expect for a variety of conditions. More
Briefing